Vladyslav SHAPOVAL - Thesis public defence

Vladyslav SHAPOVAL – TFAR CLIP  

Exploring barriers, strategies, and evaluation approaches for implementing benzodiazepine deprescribing in European older adults

Promotor: Prof. Anne Spinewine and co-promotor: Prof. Séverine Henrard

Related publication:
•    López-Toribio M et al. (submitted in June 2026).  Process evaluation of the BE-SAFE cluster randomised controlled trial: a research protocol. BMJ Open. Under review
•    Shapoval V et al. (2025). Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe. Age and Ageing.
•    Shapoval V et al. (2025). Barriers to and enablers of supporting deprescribing benzodiazepines in older adults: a survey of European nonphysician healthcare professionals. Basic & Clinical Pharmacology & Toxicology.
•    Shapoval V et al. (2025). Barriers to deprescribing benzodiazepines in older adults in a survey of European physicians. JAMA Network Open. 
 

This thesis defence took place on August 27, 2026.